Last 29.90 INR
Change Today +1.15 / 4.00%
Volume 38.1K
KILD On Other Exchanges
KILD is not on other exchanges.
As of 7:06 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

kilitch drugs (india) ltd (KILD) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/11/14 - 33.80
52 Week Low
02/25/14 - 16.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KILITCH DRUGS (INDIA) LTD (KILD)

Related News

No related news articles were found.

kilitch drugs (india) ltd (KILD) Related Businessweek News

No Related Businessweek News Found

kilitch drugs (india) ltd (KILD) Details

Kilitch Drugs (India) Limited, a pharmaceutical company, manufactures and markets various formulations in solid, liquid, and parenteral dosage forms. The company manufactures antibacterial parenteral formulations and produces sterile liquid formulations. Its products include carbapenems, cephalosporins, beta-lactam antibiotics, steroids and hormones, gastrology products, non steroidal anti inflammatory drugs, anti malarials, aminoglycosides, anti-infectives, and other products. The company also provides contract manufacturing services, including product development and manufacturing services to pharmaceutical companies. In addition, it offers various services for the execution of the projects, which include turnkey services, project consultancy services, manufacturing and process equipment supplying, installation guidelines, commissioning the project, product know-how and process technology supplying, and training. The company exports its products to various countries, such as Algeria, Burundi, Cameroon, Eritrea, Ghana, Iraq, Nigeria, Russia, Senegal, Sri Lanka, Tchad, Niger, Ethiopia, Yemen, Sudan, Tanzania, and Uganda, as well as supplies products of various manufacturers. Kilitch Drugs (India) Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Founded in 1992

kilitch drugs (india) ltd (KILD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kilitch drugs (india) ltd (KILD) Key Developments

Kilitch Drugs (India) Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Kilitch Drugs (India) Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of INR 55.604 million compared to INR 36.966 million reported a year ago. Loss from operations before other income, finance costs and exceptional items was INR 3.884 million compared to INR 2.837 million reported a year ago. Profit from ordinary activities before tax was INR 2.734 million compared to INR 17.597 million reported a year ago. Net profit was INR 4.984 million or INR 0.38 per diluted share before and after extraordinary items compared to net profit of INR 17.597 million or INR 1.31 per diluted share before and after extraordinary items reported a year ago.

Kilitch Drugs (India) Limited to Report Q1, 2015 Results on Aug 14, 2014

Kilitch Drugs (India) Limited announced that they will report Q1, 2015 results on Aug 14, 2014

Kilitch Drugs (India) Limited, Board Meeting, Aug 14, 2014

Kilitch Drugs (India) Limited, Board Meeting, Aug 14, 2014. Agenda: To consider the unaudited financial results for the Quarter ended June 30, 2014; to adopt and approve the notice and directors' report of the company along with the corporate governance report for fiscal year 2014; to finalize the dates of book closure for the purpose of forthcoming 22nd Annual General Meeting; to finalize the date venue and time for convening 22nd annual general meeting of the members of the company; and to consider the appointment of Scrutinizer to oversee the e-voting process of the company at the 22nd Annual General Meeting.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KILD:IN 29.90 INR +1.15

KILD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KILD.
View Industry Companies

Industry Analysis


Industry Average

Valuation KILD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 0.3x
Price/Cash Flow 25.4x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KILITCH DRUGS (INDIA) LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at